Clinical trial
Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia
NCT04329650 is registered in ClinicalTrials.gov with Judit Pich Martínez as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia
- Lead sponsor
- Judit Pich Martínez
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 15, 2020
- Completion date
- February 26, 2021
- Enrollment
- 163 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.